Leonard Schleifer
Net worth: 1 863 M $ as of 31/12/2025
Profile
Founder of Regeneron Pharmaceuticals, Inc., Leonard S. Schleifer is Co-President, Chief Executive Officer & Director at this company. He previously was Assistant Professor at Weill Cornell Medical College. Dr. Schleifer received a doctorate from the University of Virginia.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 15/04/2025 | 17,25,565 ( 82.56% ) | 1 332 M $ | 31/12/2025 | |
| 31/12/2025 | 6,87,981 ( 0.67% ) | 531 M $ | 31/12/2025 |
Leonard Schleifer active positions
| Companies | Position | Start |
|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Chief Executive Officer | 08/01/1988 |
Regeneron Ireland DAC
Regeneron Ireland DAC Operates as a biotechnology company which develops medicines for serious diseases | Chief Executive Officer | 01/01/2013 |
Former positions of Leonard Schleifer
| Companies | Position | End |
|---|---|---|
Weill Cornell Medical College
Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Training of Leonard Schleifer
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. Discovers, develops, manufactures and commercializes medicines for diseases | |
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weill Cornell Medical College
Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Regeneron Ireland DAC
Regeneron Ireland DAC Operates as a biotechnology company which develops medicines for serious diseases |
- Stock Market
- Insiders
- Leonard Schleifer
















